Overview

Safety of a Hypolipidemic Agent in Healthy Normal Volunteers

Status:
Completed
Trial end date:
2008-06-01
Target enrollment:
Participant gender:
Summary
The Purpose of this study is to determine the safety and tolerability of 1-MNA, a drug that is intended to be used in the treatment of elevated levels of blood fats. This study will determine the way that 1-MNA is handled by the body, and will also determine its effect on commonly measured blood fat parameters.
Phase:
Phase 1
Details
Lead Sponsor:
Pharmena North America
Treatments:
Hypolipidemic Agents